Evidence map›Paper›PMID 42834118›Full record

ArticleCell death and differentiation2026

Ubiquitination of LMP-1 by UFD-2 regulates apoptotic cell clearance.

Lei Yuan, Peiyao Li, Xinyan Li, Yingying Xi, Fuqiao Liu, Qian Zheng, Hui Wang, Hui Xiao

Abstract read
PubMed Publisher
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei Yuan *College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Peiyao Li *College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Xinyan LiCollege of Life Sciences, Shaanxi Normal University, Xi'an, China.
Yingying XiCollege of Life Sciences, Shaanxi Normal University, Xi'an, China.
Fuqiao LiuCollege of Life Sciences, Shaanxi Normal University, Xi'an, China.
Qian ZhengCollege of Life Sciences, Shaanxi Normal University, Xi'an, China.ORCID http://orcid.org/0000-0002-3466-0870
Hui WangCollege of Life Sciences, Shaanxi Normal University, Xi'an, China.
Hui XiaoCollege of Life Sciences, Shaanxi Normal University, Xi'an, China. huixiao@snnu.edu.cn.ORCID http://orcid.org/0000-0001-9305-4486

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31871387National Natural Science Foundation of China (National Science Foundation of China) 32370799Natural Science Foundation of Shaanxi Province (Shaanxi Province Natural Science Foundation) 2024JC-YBMS-638
6 · The paper itself

Abstract

Apoptotic cell clearance, or efferocytosis, is essential for tissue homeostasis and preventing inflammation in multicellular organisms. Through a genome-wide RNAi screen targeting 169 E3 ubiquitin ligases in Caenorhabditis elegans, we identified six ligases involved in efferocytosis regulation, with UFD-2 deletion showing the most significant defect. UFD-2 was found to be critical for phagosome maturation and degradation during apoptotic cell clearance. We identified the lysosomal membrane protein LMP-1 as a direct substrate of UFD-2 and showed that UFD-2 cooperates with UBC-15 to catalyze K63-linked polyubiquitination of LMP-1, essential for efficient apoptotic cell clearance. Loss of UFD-2 resulted in reduced LMP-1 levels within lysosomes and impaired activation of lysosomal DNase NUC-1. The function of UFD-2 in efferocytosis is evolutionarily conserved, as its mammalian homolog UBE4B similarly regulates apoptotic cell clearance in macrophages. These findings establish UFD-2 as a key regulator of efferocytosis, providing therapeutic insights into diseases associated with defective efferocytosis.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.